Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

NCT04541212

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Centre Hospitalier de l'université de Montréal (CHUM) Montreal, Quebec, Canada
  • CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital Montreal, Quebec, Canada
  • CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

NCT03190525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • S. Orsola Malpighi Bologna, Italy
  • Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy
  • ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy
View all 35 locations
View Trial Details
Active, Not Recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

NCT04515238

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis Augsburg, Germany
  • Universitätsklinik Köln Cologne, Germany
  • Onkologische Schwerpunktpraxis Esslingen am Neckar, Germany
  • Evangelische Krankenhaus Hamm Hamm, Germany
View Trial Details
Active, Not Recruiting

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

NCT06601504

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Wuhan Union Hospital of China Wuhan, Hebei, China
View all 16 locations
View Trial Details

Related conditions